| 0.8051 -0.013 (-1.58%) | 11-29 12:57 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 1.27  |
1-year : | 1.5 |
| Resists | First : | 1.08 |
Second : | 1.28 |
| Pivot price | 0.82 |
|||
| Supports | First : | 0.75 | Second : | 0.63 |
| MAs | MA(5) : | 0.81 |
MA(20) : | 0.89 |
| MA(100) : | 1.54 |
MA(250) : | 1.95 |
|
| MACD | MACD : | -0.2  |
Signal : | -0.2 |
| %K %D | K(14,3) : | 11.9 |
D(3) : | 11.4 |
| RSI | RSI(14): 29.7 |
|||
| 52-week | High : | 3.45 | Low : | 0.75 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ CHEK ] has closed above bottom band by 42.8%. Bollinger Bands are 34.6% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 0.8 - 0.81 | 0.81 - 0.81 |
| Low: | 0.77 - 0.78 | 0.78 - 0.78 |
| Close: | 0.79 - 0.8 | 0.8 - 0.81 |
Check-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.
Tue, 19 Nov 2024
Check Cap Ltd stock hits 52-week low at $0.76 amid sharp decline - Investing.com
Fri, 08 Nov 2024
Check Cap Ltd stock hits 52-week low at $1.07 amid downturn - Investing.com
Thu, 31 Oct 2024
Check Cap Ltd stock hits 52-week low at $1.11 amid market challenges - Investing.com
Fri, 13 Sep 2024
Check-Cap Announces Leadership Changes and Nobul Deal - TipRanks
Mon, 05 Aug 2024
Check-Cap Ltd. Announces Major Board Changes - TipRanks
Thu, 28 Mar 2024
Check-Cap Ltd. Announces Merger with Nobul AI - TipRanks
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NASDAQ
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Diagnostics & Research
|
|
| Shares Out | 6 (M) |
| Shares Float | 4 (M) |
| Held by Insiders | 25 (%) |
| Held by Institutions | 0.2 (%) |
| Shares Short | 14 (K) |
| Shares Short P.Month | 12 (K) |
| EPS | -3 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 4.05 |
| Profit Margin | 0 % |
| Operating Margin | 0 % |
| Return on Assets (ttm) | -31.7 % |
| Return on Equity (ttm) | -54.1 % |
| Qtrly Rev. Growth | 0 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 0 |
| EBITDA (p.s.) | -3.02 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | -17 (M) |
| Levered Free Cash Flow | -12 (M) |
| PE Ratio | -0.27 |
| PEG Ratio | 0 |
| Price to Book value | 0.19 |
| Price to Sales | 0 |
| Price to Cash Flow | -0.28 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|